Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

NCT00450892 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

129

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: docetaxel+lapatinib
DRUG: docetaxel + trastuzumab
DRUG: docetaxel + trastuzumab + lapatinib

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]